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Abstract
Core-shell alginate-poly (lactic-co-glycolic) acid (PLGA) microparticles are potential candidates to improve hydrophilic
drug loading while facilitating controlled release. This report studies the influence of the alginate core size on
the drug release profile of alginate-PLGA microparticles and its size. Microparticles are synthesized through
double-emulsion fabrication via a concurrent ionotropic gelation and solvent extraction. The size of alginate core
ranges from approximately 10, 50, to 100 μm when the emulsification method at the first step is homogenization,
vortexing, or magnetic stirring, respectively. The second step emulsification for all three conditions is performed with
magnetic stirring. Interestingly, although the alginate core has different sizes, alginate-PLGA microparticle diameter
does not change. However, drug release profiles are dramatically different for microparticles comprising different-sized
alginate cores. Specifically, taking calcein as a model drug, microparticles containing the smallest alginate core (10 μm)
show the slowest release over a period of 26 days with burst release less than 1 %.
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Background
Core-shell structures are synthesized through the combin-
ation of a polymeric core as well as another polymeric ma-
terial over it [1–3]. Previous studies demonstrated that
drug-loaded core-shell particles showed better controlled
release compared to monolithic composite microparticles
[4]. As such, combinations of different polymers having
dissimilar diffusion kinetics and degradation rates can be
tuned to achieve better control over drug release [5].
Alginate-poly (lactic-co-glycolic) acid (alginate-PLGA)
core-shell microparticles are promising drug carriers
with high loading efficiency for hydrophilic drugs and
good control over the drug release kinetics. They are
composed of a hydrogel alginate core and a polyester
PLGA shell. While hydrophilic drugs such as proteins
can be encapsulated within the alginate core [6–9], the
PLGA shell stabilizes the alginate core to prevent burst
release and prolong drug release. Previously, Lim et al.
reported the successful synthesis of alginate-PLGA
microparticles via solvent extraction method and used
them to deliver metoclopramide hydrochloride [4].
Loading efficiency results showed a 29 % increase in
encapsulation efficiency for alginate-PLGA compared
to neat PLGA particles.
This study aims to study the influence of the alginate
core size on the drug release profile of alginate-PLGA
microparticles and its overall size. The size of the al-
ginate hydrogel core was controlled through choosing
different emulsification methods at the first step (Fig. 1).
Homogenization, vortexing, and magnetic stirring pro-
duced approximately 10, 50, and 100 μm alginate cores,
respectively. As the emulsification during the second
step was performed using magnetic stirring, the overall
alginate-PLGA microparticles in all three conditions
attained a similar size (i.e. 100 μm). However, the drug
release profiles were dramatically different for micro-
particles comprising different-sized alginate cores. Spe-
cifically, taking calcein as a model drug, microparticles
containing the smallest alginate core (10 μm) showed the
slowest release over a period of 26 days with negligible
burst release, compared with pure PLGA microparticles.
Herein, particle nomenclature was given based on the
sequence of the fabrication methods: homogenization
(homo), vortexing (vort), and magnetic stirring (mag).
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As an illustration, a particle utilizing homogenizer (first
emulsion) followed by magnetic stirrer (second emul-
sion) would be termed: homo-mag particles.
Methods
All materials except specifically mentioned were obtained
from Sigma-Aldrich.
Synthesis of PLGA Microparticles
The PLGA microparticles were synthesized according
to the published method [10]. Briefly, 50 mg of PLGA
(molecular weight (Mw) 30,000–60,000) was dissolved
in 2 ml chloroform and mixed with 0.2 ml of calcein
aqueous solution (1 mg/ml). This mixture was then ho-
mogenized at speed 25,600 rpm (Scilogex D160) for
10 s. Later, the solution was added dropwise to 20 ml
of 3 % polyvinyl alcohol (PVA) (Mw 9000–10,000, 80 %
hydrolyzed) aqueous solution under magnetic stirring at
600 rpm. These particles were termed homo-mag. The
solution was placed in 40 °C water batch for 2.5 hrs. Fi-
nally, the PLGA microparticles were collected through
centrifugation and washed with DI water trice. Vort-
mag particles on the other hand were fabricated by vor-
texing at 2,500rpm for PLGA and magnetic stirring at
600rpm in PVA. Lastly for mag-mag particles both
steps were done with magnetic stirring at 600 rpm.
Synthesis of Alginate-PLGA Microparticles
Fifty milligrams of PLGA was dissolved in 2 ml of
chloroform with 1 % (w/v) Span 80. One milliliter of
1.35 M sodium chloride aqueous solution was mixed
with 0.2 ml of calcein aqueous solution (1 mg/ml) and
0.2 ml of 4.5 % (w/v) sodium alginate aqueous solution.
The aqueous mixture was then added into the PLGA
solution and emulsified using homogenization, vortex-
ing, or magnetic stirring. This water-oil emulsion was
added dropwise into 20 ml of 3 % PVA solution con-
taining 50 mM calcium chloride and 0.6 M sodium
chloride under magnetic stirring. The solution was
placed in 40 °C water batch for 2.5 h. Finally, the
alginate-PLGA microparticles were collected through
centrifugation and washed with DI water trice. Homo-
mag, vort-mag, and mag-mag alginate-PLGA micro-
particles were fabricated as above.
SEM Characterization of Microparticles
The particles were lyophilized for 24 h [11]. Then, the
lyophilized particles were placed onto the carbon tape
on the SEM stub. Excess loose particles could be re-
moved using compressed air. The samples were then
coated with platinum and imaged with JEOL JSM 6701F
SEM under the beam strength of 5 kV [12].
Fig. 1 Schematic of the synthesis of alginate-PLGA core-shell microparticles through three methods
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Calculation of Calcein Encapsulation Efficiency
The calcein loading efficiency of the alginate-PLGA micro-
particles was calculated by using the following equation:





where Mi is initial amount of calcein during the prepar-
ation and Ms is the amount of non-encapsulated calcein
in the supernatant [13].
Study of Calcein Release Profile from Microparticles
PLGA or alginate-PLGA microparticles (25 mg) were
dispersed in 1 ml PBS at 37 °C. At 0 h, 2 h, days 1–6, 19,
and 26, the particles were separated from the solution
through centrifugation and dispersed in the fresh buffer.
The supernatant was examined for their calcein concentra-
tion through fluorescence measurement (λex 485 nm; λem
535 nm) [14]. The release profile was derived based on the
cumulative sum of released amounts at specific times.
Results
Synthesis and Characterization of Alginate-PLGA
Microparticles
Alginate-PLGA microparticles were synthesized through
double emulsion. First, the alginate solution was emulsified
in a chloroform solution containing PLGA (water-oil) with
the model drug (i.e. calcein) contained within the alginate
solution. Emulsification was performed using three differ-
ent methods, homogenization (25,600 rpm), vortexing
(2500 rpm), and magnetic stirring (600 rpm). Subsequently,
the emulsified mixture was added dropwise into the PVA
solution containing calcium chloride under magnetic stir-
ring. The calcium chloride gelated the alginate core during
the preparation. As shown in Fig. 2, all three methods
produced similar-sized alginate-PLGA microparticles at
approximately 100 μm. However, the microparticles syn-
thesized through the first homogenization followed by
magnetic stirring contained many fluorescence particles
approximately 10 μm and smaller (Fig. 2a). Microparticles
prepared through vortexing and magnetic stirring appeared
to contain fluorescence particles 50 μm and below (Fig. 2b).
Those prepared using two magnetic stirring steps appeared
to consist of a monolithic core within a thin PLGA outer
shell (Fig. 2c). This suggests that different agitation
methods can be used during the initial agitation step to
manipulate the core size of the hydrophilic alginate phase
within the PLGA shell.
To estimate the amount of encapsulated calcein by each
particle formulation, the remaining calcein obtained from
the supernatant (following double emulsion) was deducted
from the input amount of calcein. Briefly, calcein concen-
tration was determined by measuring the fluorescence of
the supernatant and fitted to a standard curve generated
from known concentrations (Additional file 1: Figure S1).
The calculation showed that microparticles containing 10
or 50 μm alginate had encapsulation efficiency of over
90 % (Additional file 2: Figure S2). Microparticles contain-
ing 100 μm alginate core (monolithic-like particles) only
had an efficiency of ~30 %.
Calcein Release Profile of Alginate-PLGA Microparticles
The calcein release profile was next examined for the three
different alginate-PLGA microparticle formulations. The par-
ticles were dispersed in phosphate buffered saline (PBS) for
26 days, and the supernatant of the particle solution was ana-
lysed for their fluorescence intensity at different time points.
As shown in Fig. 3a, all three alginate-PLGA microparticles
showed a steady release of calcein over the period. Although
microparticles containing 100 μm alginate cores (mag-mag)
had the lowest encapsulation efficiency, their calcein release
was the most rapid. Nevertheless, all three microparticle for-
mulations only released less than 1 % of the loaded calcein
over a period of 26 days. In comparison, calcein encapsulated
within similar-sized double emulsion PLGA microparticles
without alginate cores, 9 % of the encapsulated calcein was
released over the same period (Fig. 3b). It is worth noting
that the burst release observed at days 1 and 5 in the double
emulsion PLGA particles (without hydrogel core) was not
observed for alginate-PLGA microparticles.
Fig. 2 Representative fluorescence images of alginate-PLGA microparticles containing a 10, b 50, and c 100 μm alginate cores (scale bar: 50 μm)
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Further Examination of Alginate-PLGA Microparticles
Containing 10 μm Alginate Core
Based on the above analysis, alginate-PLGA microparticles
containing 10 μm alginate cores demonstrated the highest
calcein encapsulation efficiency (Additional file 2: Figure
S2) and the slowest calcein release over 26 days. Further
studies were carried for examining the microstructure of
this type of microparticles. As shown in Fig. 4a, alginate-
PLGA microparticles showed a spherical structure. Closer
examination of sectioned particles revealed the presence of
many microsized cores within the alginate-PLGA micro-
particles (Fig. 4b). This confirmed the observation obtained
from fluorescence imaging (Fig. 2a). After 26 days of incu-
bation in PBS, the PLGA shell of the microparticles got
etched significantly (Fig. 4c), losing its spherical morph-
ology and attaining a rougher and less defined appearance.
Discussion
Drug release systems promise improved delivery efficiency,
enhanced patient compliance, and reduced side effects [15].
Alginate-PLGA core-shell microparticle system is such a
promising platform, in which the alginate core reserves
the hydrophilic drugs while the PLGA shell entraps the
core, tuning release profile. However, no studies have
been performed to examine the influence of core size
in core-shelled particles on drug release kinetics. This
article aims to explore the influence of alginate core
size on the overall size of alginate-PLGA microparticles
and their release profile.
PLGA microparticles delivering hydrophilic payloads are
often fabricated using a double emulsion solvent evapor-
ation method, comprising: (a) preparing a water-in-oil (w/
o) emulsion, (b) emulsifying the primary w/o within an
aqueous phase containing surfactants, and (c) the organic
solvent is evaporated to create the particles [16]. In this
study, the emulsifying method in step 1 was chosen from
magnetic stirring, vortexing, or homogenization while
other parameters were kept the same (Fig. 1). Varying
the primary emulsion method worked as intended. Al-
though the overall size of alginate-PLGA microparticles
was similar, different-sized alginate cores were observed
(Fig. 2). Specifically, reducing the rate of emulsification
from homogenization (25,600 rpm) to vortexing (2500 rpm)
to magnetic stirring (600 rpm), the alginate cores simi-
larly increased from 10 to 50 to 100 μm. This was due
to the different magnitudes of shear stress generated
from various emulsification methods. Higher shear stress
is a result of higher speed of emulsification [17, 18].
Alginate-PLGA microparticles showed higher encapsu-
lation efficiency as compared to the corresponding parti-
cles without alginate core (Additional file 2: Figure S2
and Additional file 3: Figure S3). This improvement may
Fig. 3 a Comparison of calcein release profiles of alginate-PLGA microparticles made through magnetic stirring in both steps (mag-mag), through
vortexing and magnetic stirring (vort-mag), or through homogenization and magnetic stirring (homo-mag). b Comparison of calcein release profiles of
alginate-PLGA microparticles made through homo-mag and PLGA microparticles made through homo-mag
Fig. 4 SEM examination of alginate-PLGA microparticles: a alginate-PLGA microparticles containing 10 μm alginate cores (homo-mag). Scale bar:
200 μm. b A cross-section image of alginate-PLGA microparticles from a. c Alginate-PLGA microparticles containing 10 μm alginate cores after
26 days of incubation in PBS. Scale bar: 200 µm (a, c); 50 µm (b)
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be due to the high affinity between calcein and calcium
ions which were used for gelation of alginate core [19, 20].
This allowed a greater quantity of calcein to be entrapped
within particles bearing alginate cores.
Finally, the drug release profile of the influence of
alginate core size was examined. Microparticles were
dispersed in PBS at 37 °C for 26 days. As shown in
Fig. 3a, smaller alginate core size resulted in slower
calcein release. Previous study showed that drug re-
lease occurred when water diffuses into the interior
causing drug dissolution and subsequently diffusion
across the shell to the exterior [21, 22]. Thus, a high
inner surface-area-to-volume ratio (homo-mag) provides a
longer diffusion distance for water penetration into the
core as compared to low inner surface-to-volume ratio
(mag-mag), leading to a slower calcein release.
As compared to PLGA microparticles without alginate
cores, alginate-PLGA microparticles surprisingly did not
exhibit significant burst release (Fig. 3b). This observa-
tion may be a result of the high affinity between calcium
ions and calcein, which hinders the release of calcein
molecules [19, 20].
Conclusions
In this study, alginate-PLGA microparticles were synthe-
sized through double emulsion solvent extraction and
concurrent ionotropic gelation. The alginate core size was
tuned by utilizing different emulsification techniques in the
first emulsification step. A higher speed of emulsification
produced a smaller alginate core. Taking calcein as a model
drug, the alginate-PLGA particles with smaller alginate
cores showed the slowest drug release. And compared with
pure PLGA particles, burst release of drugs in all alginate-
PLGA particles was significantly suppressed. In summary,
the control of alginate core size in the alginate-PLGA core-
shell microparticles proved to be an effective way to tailor
the drug release profile.
Additional files
Additional file 1: Figure S1. The standard curve of fluorescence vs
calcein concentration. Fluorescence with emission/excitation of 485/
535nm = {3.82 × [calcein concentration, µM]2} + {67.16 × [calcein
concentration, µM]} was obtained with coefficient of determination,
R2 = 0.997.
Additional file 2: Figure S2. Calcein encapsulation efficiency for
alginate-PLGA microparticles containing different sizes of alginate core.
Alginate-PLGA microparticles containing 10 and 50µm alginate cores
(homo-mag and vort-mag) demonstrated the high calcein encapsulation
efficiency as compared to mag-mag alginate-PLGA microparticles.
Additional file 3: Figure S3. Calcein encapsulation efficiency for PLGA
microparticles containing different PLGA core sizes. PLGA microparticles
demonstrated lower encapsulation efficiency as compared to alginate-
PLGA microparticles in Additional file 2.
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